DRUG · Unmapped registry intervention
Ecnoglutide high dosage
Find medicine records ·
Find other trials using this name
Clinical trial
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
NCT05680129
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Ecnoglutide low dosage
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Dulaglutide
Normalized identity: dulaglutideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
DulaglutideDRUG · verified · RxNorm: dulaglutide
MetforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Hangzhou Sciwind Biosciences Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05680129 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.